Literature DB >> 11551372

Choices and goals in the treatment of the diabetic hypertensive patient.

E Basta1, G Bakris.   

Abstract

The number of people living in the United States who have diabetes and high blood pressure is over 11 million and rising. Together, these two diseases are devastating to the whole body if not aggressively controlled. The tight recommendations put forth by the Joint National Committee VI for better control of blood pressure and control of proteinuria have helped diminish further organ failure in patients with hypertension and diabetes. Combination therapy has been found to be very effective, and one arm should be an angiotensin converting enzyme inhibitor.

Entities:  

Mesh:

Year:  2001        PMID: 11551372     DOI: 10.1007/s11906-001-0055-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  28 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  By the numbers. The facts about diabetes.

Authors:  J Arent
Journal:  Healthplan       Date:  2000 Jan-Feb

Review 3.  The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

Authors:  F A McAlister; N R Campbell; K Zarnke; M Levine; I D Graham
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

4.  The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.

Authors:  C D Agardh; E Agardh; O Torffvit
Journal:  Diabetes Res Clin Pract       Date:  1997-03       Impact factor: 5.602

5.  Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.

Authors:  G L Bakris; A Mangrum; J B Copley; N Vicknair; R Sadler
Journal:  Hypertension       Date:  1997-03       Impact factor: 10.190

Review 6.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Authors:  G L Bakris; M Williams; L Dworkin; W J Elliott; M Epstein; R Toto; K Tuttle; J Douglas; W Hsueh; J Sowers
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

7.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

8.  Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

Authors:  P Rossing; P Hougaard; K Borch-Johnsen; H H Parving
Journal:  BMJ       Date:  1996-09-28

9.  [Significance of proteinuria and hypertension in the prognosis of type 1 diabetes. Results of a 10-year follow-up study on micro- and macrovascular disease mortality].

Authors:  K P Ratzmann; M Rasković; H Thoelke
Journal:  Dtsch Med Wochenschr       Date:  1989-09-01       Impact factor: 0.628

10.  Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.

Authors:  T Hannedouche; P Landais; B Goldfarb; N el Esper; A Fournier; M Godin; D Durand; J Chanard; F Mignon; J M Suo
Journal:  BMJ       Date:  1994-10-01
View more
  1 in total

1.  Is there a relationship between sleep apnoea and microalbuminuria?

Authors:  Melek Cihanbeylerden; Melike Bağnu Yüceege
Journal:  Sleep Breath       Date:  2021-08-13       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.